NT_1170x120_1-11-18

generic drugs

GPhA tabs Davis as new CEO

GPhA tabs Davis as new CEO

WASHINGTON — Chester “Chip” Davis has been named president and chief executive officer of the Generic Pharmaceutical Association (GPhA), taking over from Ralph Neas, who is stepping down. GPhA said Wednesday that Davis, previously executive vice president for advocacy and member relations at Pharmaceutical Research and Manufacturers of America (PhRMA), is slated to start in

NCPA turns spotlight on underpayment for generics

NCPA turns spotlight on underpayment for generics

ALEXANDRIA, Va. — The National Community Pharmacists Association said it has compiled evidence that underscores the need for federal sunshine legislation to provide more insight into below-cost reimbursements from pharmacy benefit managers that don’t keep pace with rising market costs for generic drugs. NCPA said Monday that it recently asked members for examples illustrating the

Cardinal Health to buy Harvard Drug Group

Cardinal Health to buy Harvard Drug Group

DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.115 billion. Cardinal said Friday that it will use cash and new debt to finance the transaction, which is expected to close in the beginning of its 2016 fiscal year,

Sam’s Club serves up free generics

Sam’s Club serves up free generics

BENTONVILLE, Ark. — Sam’s Club is offering some generic drugs free under an expanded prescription savings program. The Walmart warehouse club chain said Thursday five generic medications are now available in specified quantities at no charge in 35 states for its Sam’s Club Plus and Business Plus members. They include donepezil (for Alzheimer’s disease), pioglitazone

Apotex exec to chair Canadian Generic Pharmaceutical Association

Apotex exec to chair Canadian Generic Pharmaceutical Association

TORONTO — Jeff Watson, president of global generics at Apotex, has been elected as chairman of the Canadian Generic Pharmaceutical Association (CGPA). CGPA also said Monday that Larry MacGirr, chief operating officer of Pharmascience, has been elected as the association’s vice chairman. “It is an honor to serve as chair of CGPA, particularly during this period

Generics drugs loom larger than ever in health care

Generics drugs loom larger than ever in health care

NEW YORK — As the nation becomes more focused on affordable health care, generic drug companies are carving out a larger share of the U.S. market for prescription drugs. Perhaps the most significant sign of this continuing shift to generic drug utilization shows up in the market share data for actual prescriptions dispensed, brands compared

Senate report calls for higher generics usage

WASHINGTON — Providing incentives to prescription drug plan sponsors that increase generic drug use is among recommendations that the Senate Special Committee on Aging unveiled last month in a bipartisan report that focuses on ways to increase the utilization of generics within the Medicare Part D program. The panel also heard about industry issues beyond